February 15, 2012 Summary: On March 2, 2012, take advantage of the opportunity to chat live with Cleveland Clinic atrial fibrillation experts, Dr. David Van Wagoner, Dr. Walid Saliba, and Dr. Mandeep Bhargava. Our previous chats with doctors from the Cleveland Clinic have been so popular that they have agreed to do another one with …
Read MoreAll News
By Mellanie True Hills January 26, 2012 Summary: Our blog post on avoiding dehydration from coffee, alcohol, and flying was just published in Grand Rounds: Health Tips at USATODAY.com Reading time: 3-4 minutes, which includes the article referenced We’re thrilled that one of our favorite blog posts, on avoiding dehydration from coffee, alcohol, and flying, …
Read MoreBy Mellanie True Hills January 25, 2012 Summary: In this video interview, Dr. Daniel Singer of Harvard discusses the information about new anticoagulants for atrial fibrillation stroke prevention that he presented at the Boston Atrial Fibrillation Symposium, which included dabigatran, rivaroxaban, apixaban, and edoxaban. Reading and watching time is approximately 5–6 minutes Dr. Daniel Singer, …
Read MoreNew 2012 HRS/EHRA/ECAS Atrial Fibrillation Ablation Guidelines presented by Dr. Hugh Calkins — Video
By Mellanie True Hills January 24, 2012 Summary: In this video, Dr. Hugh Calkins, Johns Hopkins electrophysiologist, discusses the new 2012 atrial fibrillation guidelines for catheter ablation and surgical ablation, which he presented at Boston Atrial Fibrillation Symposium 2012. Reading and watching time is approximately 7–8 minutes At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh …
Read MoreSummary: Read Dr. John Mandrola’s Boston Atrial Fibrillation Symposium 2012 notes and recap Reading time: Approximately 8–10 minutes for all articles below January 19, 2012 — Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged from Boston Atrial Fibrillation Symposium this year. We thought his posts were a …
Read MoreJanuary 16, 2012 Guest post by Dr. John Mandrola Whew. The Boston AF symposium digests slowly. Processing nearly the entirety of AF into just three days borders on ridiculous. Well at least for us regular guys, you know, those of us that doctor, not model things mathematically. This year, I tried something new: posting slightly …
Read MoreJanuary 14, 2012 Guest post by Dr. John Mandrola Today is the third and final day of the Boston AF symposium. (My editorial comments in italics.) Dr Hugh Calkins started the day by reviewing the major clinical trials of AF ablation. A lot of these I have written about previously. One of the most pivotal …
Read MoreJanuary 13, 2012 Guest post by Dr. John Mandrola The late-morning sessions addressed the possible mechanism(s) of AF. Many ask what causes AF. The assumption holds that if we can ablate AF, we must know what causes it. This would not be true. One line of thinking holds that disorganized electrical conduction throughout the atria …
Read MoreJanuary 13, 2012 Guest post by Dr. John Mandrola Dr. Frank Marchlinski moderated the first sessions: The global topic involved pulmonary vein reconnections. This is the bane of AF ablation. Our inability to broach the 80% success rates has most to do with the fact that PVs don’t stay isolated. Everyone wants to enhance the …
Read MoreJanuary 12, 2012 Guest post by Dr. John Mandrola The second half of the day was fast paced and full of information. Folks, these are rough notes. Hope they help…Again my random thoughts are in italics. Dr Eric Prystowsky led off the afternoon with the best clinical papers of 2011: He is a great speaker …
Read More